Cleared Special

StatStrip Xpress 2 Glucose Hospital Meter System

K163490 · Nova Biomedical Corporation · Chemistry
Jan 2017
Decision
25d
Days
Class 2
Risk

About This 510(k) Submission

K163490 is an FDA 510(k) clearance for the StatStrip Xpress 2 Glucose Hospital Meter System, a Prescription Use Blood Glucose Meter For Near-patient Testing (Class II — Special Controls, product code PZI), submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on January 6, 2017, 25 days after receiving the submission on December 12, 2016. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K163490 FDA.gov
FDA Decision Cleared SESE
Date Received December 12, 2016
Decision Date January 06, 2017
Days to Decision 25 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code PZI — Prescription Use Blood Glucose Meter For Near-patient Testing
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.1345
Definition Intended For Use In Near-patient Testing Settings For In Vitro Diagnostic, Multiple-patient Use For The Quantitative Determination Of Glucose Throughout All Hospital And All Professional Healthcare Settings For Use In Determining Dysglycemia.

Similar Devices — PZI Prescription Use Blood Glucose Meter For Near-patient Testing

All 12
XPER Technology PREMIUM Pro Blood Glucose Monitoring System
K221349 · Taidoc Technology Corporation · Nov 2024
cobas pulse blood glucose monitoring system
K220272 · Roche Diagnostics · Apr 2024
StatStrip Glucose Hospital Meter System
K232075 · Nova Biomedical Corporation · Feb 2024
Assure Titanium Blood Glucose Monitoring System
K200788 · Arkray, Inc. · May 2022
StatStrip Xpress 2 Glucose Hospital Meter System
K182549 · Nova Biomedical Corporation · Dec 2018
StatStrip Xpress Glucose Hospital Meter System
K182552 · Nova Biomedical Corporation · Dec 2018